A Review of Literature on the Impact of COVID-19 Pandemic towards Chronic Disease and Medication Management

Wei Thing Sze

Abstract


COVID-19 has changed the daily living of people, especially those who have chronic diseases and taking long term medications. The aim of this study is to review the recent evidences on the impact of COVID-19 pandemic towards chronic disease and medication management. The database and search engines used for this literature review are PubMed and Google Scholar. Abstracts were reviewed for relevance to the topic and a total of 17 articles were deemed pertinent to be summarised in this review. Eleven publications addressed a common issue, which was the cancellation or postponement of medical consultations or procedures. Seven publications stated psychological impact as a major effect caused by this pandemic. COVID-19 has also impacted the lifestyle of patients with chronic diseases due to reduced opportunity to go outdoors, inaccessible to fresh food, economic hardship and poverty. There was a shift in focus of pharmaceutical manufacturers to producing medical equipment and pharmaceutical preparations to fight against COVID-19, as well as difficulties in medication distributions owing to lockdown measures.  A relationship between COVID-19 pandemic and worsening of chronic diseases were reported. Evidence-based strategies are needed to better direct the management of chronic diseases and medication management during this unprecedented time  and beyond.


References


“Coronavirus.” https://www.who.int (accessed May. 19, 2021).

E. Monaghesh and A. Hajizadeh, “The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence,” BMC Public Health. 20(1): 1193, 2020.

Y. V. Chudasama et al., “Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals,” Diabetes Metab. Syndr. Clin. Res. Rev. 14(5): 965–967, 2020.

T. Truong, M. Dittmar, A. Ghaffari, and E. Lin, “Policy and Pandemic: The Changing Practice of Nephrology During the Coronavirus Disease-2019 Outbreak,” Adv. Chronic Kidney Dis.: 27(5): 390–396, 2020.

I. A. Kretchy, M. Asiedu-Danso, and J.-P. Kretchy, “Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries,” Res. Soc. Adm. Pharm. 17(1): 2023–2026, 2021.

A. Bhatia, M. Kc, and L. Gupta, “Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions,” Rheumatol. Int. 41(5): 843–850, 2021.

K. Palmer et al., “The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing,” Aging Clin. Exp. Res. 32(7): 1189–1194, 2020.

A. Y. Chang, M. R. Cullen, R. A. Harrington, and M. Barry, “The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review,” J. Intern. Med. 289(4): 450–462, 2021.

C. N. Floyd and A. S. Wierzbicki, “Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill?,” Curr. Opin. Cardiol. 35(4): 428–433, 2020.

G. Di Tano, S. Verde, M. Loffi, R. De Maria, and G. B. Danzi, “Impact of the COVID-19 pandemic on the management of heart failure outpatient clinics. Lessons during the lockdown restrictions,” G. Ital. Cardiol. 2006. 21(10): 750–756, 2020.

P. Yerram and M. Misra, “Home Dialysis in the Coronavirus Disease 2019 Era,” Adv. Chronic Kidney Dis. 27(5): 442–446, 2020.

A. E. Caballero et al., “COVID-19 in people living with diabetes: An international consensus,” J. Diabetes Complications. 34(9): 107671, 2020.

E. B. Tapper and S. K. Asrani, “The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care,” J. Hepatol. 73(2): 441–445, 2020.

L. Sher, “The impact of the COVID-19 pandemic on suicide rates,” QJM Mon. J. Assoc. Physicians. 113(10): 707–712, 2020.

F. Puntillo et al., “Impact of COVID-19 pandemic on chronic pain management: Looking for the best way to deliver care,” Best Pract. Res. Clin. Anaesthesiol.34(3): 529–537, 2020.

N. M. Oreskovic, T. B. Kinane, E. Aryee, K. A. Kuhlthau, and J. M. Perrin, “The Unexpected Risks of COVID-19 on Asthma Control in Children,” J. Allergy Clin. Immunol. Pract. 8(8): 2489–2491, 2020.

A.-S. Vanherwegen, C. Gysemans, and C. Mathieu, “Regulation of Immune Function by Vitamin D and Its Use in Diseases of Immunity,” Endocrinol. Metab. Clin. North Am. 46(4): 1061–1094, 2017.

A. Ghosh, B. Arora, R. Gupta, S. Anoop, and A. Misra, “Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India,” Diabetes Metab. Syndr. 14(5): 917–920, 2020.

J. S. Bell, L. Reynolds, C. Freeman, and J. K. Jackson, “Strategies to promote access to medications during the COVID-19 pandemic,” Aust. J. Gen. Pract. 49(8): 530–532, 2020.

M. Viswanathan et al., “Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review,” Ann. Intern. Med. 157(11): 785–795, 2012.

F. M. Szymanski, C. Smuniewski, and A. E. Platek, “Will the COVID-19 Pandemic Change National Security and Healthcare in the Spectrum of Cardiovascular Disease?,” Curr. Probl. Cardiol., vol. 45, no. 9, p. 100645, Sep. 2020, doi: 10.1016/j.cpcardiol.2020.100645.

M. M. Liu, A. B. Reidy, S. Saatee, and C. D. Collard, “Perioperative Steroid Management: Approaches Based on Current Evidence,” Anesthesiology. 127(1): 166–172, 2017.

M. E. Hall et al., “Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic,” J. Card. Fail. 26(6): 462–463, 2020.

J. M. Plevinsky et al., “The Impact of COVID-19 on Pediatric Adherence and Self-Management,” J. Pediatr. Psychol. 45(9): 977–982, 2020.

G. A. Millett et al., “Assessing differential impacts of COVID-19 on black communities,” Ann. Epidemiol.: 47: 37–44, 2020.

M. Jenco, “Study: COVID-19 pandemic exacerbated hardships for low-income, minority families,” AAP News, Jul. 2021, Accessed: Jul. 19, 2021. [Online]. Available: https://www.aappublications.org/news/2020/06/03/covid19hardships060320

A. van Dorn, R. E. Cooney, and M. L. Sabin, “COVID-19 exacerbating inequalities in the US,” Lancet Lond. Engl. 395(10232): 1243–1244, 2020.

B. E. Compas, S. S. Jaser, M. J. Dunn, and E. M. Rodriguez, “Coping with chronic illness in childhood and adolescence,” Annu. Rev. Clin. Psychol.: 8: 455–480, 2012.




DOI: http://doi.org/10.11591/ijphs.v11i3.21167

Refbacks

  • There are currently no refbacks.


International Journal of Public Health Science (IJPHS)
p-ISSN: 2252-8806, e-ISSN: 2620-4126

View IJPHS Stats

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.